About This Archive | DCHAS-L 2020 Index | DCHAS-L Yearly Index | DCHAS-L Home Page
From: Lisa Zeise <lisa**At_Symbol_Here**MEL-CO.COM>
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th
Date: Apr 10, 2020 20:41 UTC
Reply-To:
ACS Division of Chemical Health and Safety
In-Reply-To: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th
Thank you Zack. I tossed four drafts to the email you just answered�
Lisa
From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU>
On Behalf Of Zack Mansdorf
Sent: Friday, April 10, 2020 1:26 PM
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th
Monna:
First, we actually have tested more people than any other country in the world. Some of the testing in some countries (such as China) had poor reliability. Antibodies normally indicate that you are over the infection if you are walking
around versus being treated and I am not aware of any test for "shedding". Tests for having the infection would not make sense if you have no symptoms (it is not practical to test 320 million people). Having a negative test on Tuesday, means you do not have
the virus on Tuesday. Maybe you get it Wednesday.
Zack
From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU>
On Behalf Of Monona Rossol
Sent: Friday, April 10, 2020 2:38 PM
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th
Gee, how about we test people? There are tests for shedding, tests for anitbodies (doesn't mean you still aren't shedding) and tests
for just plain having the virus. We see a lot more testing in other countries. You can't fix what you can't track. Monona
-----Original Message-----
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Sent: Fri, Apr 10, 2020 11:33 am
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th
While it is true that perhaps as much as 50% or those infected are asymptomatic, what else can be done as a screen in the absence of a readily available quick turn-around
test for the virus or antibodies?
Temperature screening was more effective with SARS-1 since it looked like the asymptomatic were not infectious.
At least a temperature screen will identify _some_ of those infected. These days, the perfect cannot be the enemy of the "sort-of OK."
Peter Zavon, CIH
Penfield, NY
PZAVON**At_Symbol_Here**Rochester.rr.com
From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU>
On Behalf Of Monona Rossol
Sent: Thursday, April 9, 2020 10:04 PM
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th